Effects of Skeletal Anchored Maxillary Expander for Constricted Maxilla

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-25
SponsorSamar Hassan Mahmoud Mohamed

About this trial

The aim of study will be Evaluation of Effects of skeletal anchored maxillary expander for constricted maxilla with different patient's age

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Skeletal maxillary transverse deficiency.

Unilateral or bilateral posterior crossbite. .Patient maintains good oral hygiene and overall health.

Patient with no previous orthodontic treatment.

No systemic disease that may affect bone quality or interfere with orthodontic treatment.

Disqualifiers

Craniofacial congenital disorders, including cleft lip and palate.

History of periodontal disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Skeletal Anchored Maxillary Expander (MARPE)

    Device

    Mini implant assisted rapid maxillary expander (MARPE) used for skeletal maxillary expansion in adolescent and adult patients

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Adolescent groupExperimental treatment 1 intervention
Group B: Adult groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Skeletal and dental changes after skeletal anchored maxillary expander for constricted maxilla in adolescent and adult patients constricted maxilla in adolescent and adult patients

changes in maxillary skeletal and dental arch width assessed by CBCT imaging before and after MARPE treatment.. evaluation includes skeletal expansion and transverse dental arch changes

Time frame
from baseline (T0) to post expansion (T1)approximately 3 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Samar Hassan Mahmoud Mohamed

Lead sponsor

Al-Azhar University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: